| 0 |
Microtubule Inhibitor [EPC] |
28 |
0.0002 |
| 1 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
3 |
0.0001 |
| 2 |
HER2/neu Receptor Antagonist [EPC] |
7 |
0.0001 |
| 3 |
Platinum-based Drug [EPC] |
21 |
0.0001 |
| 4 |
Alkylating Drug [EPC] |
13 |
0.0001 |
| 5 |
Progesterone [EPC] |
1 |
0.0000 |
| 6 |
Cardiac Glycoside [EPC] |
3 |
0.0000 |
| 7 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
2 |
0.0000 |
| 8 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
3 |
0.0000 |
| 9 |
Cholinergic Muscarinic Antagonist [EPC] |
1 |
0.0000 |
| 10 |
RANK Ligand Inhibitor [EPC] |
5 |
0.0000 |
| 11 |
Aromatase Inhibitor [EPC] |
2 |
0.0000 |
| 12 |
Methylxanthine [EPC] |
1 |
0.0000 |
| 13 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 14 |
Topoisomerase Inhibitor [EPC] |
1 |
0.0000 |
| 15 |
Nucleoside Analog Antiviral [EPC] |
1 |
0.0000 |
| 16 |
Central Nervous System Stimulant [EPC] |
1 |
0.0000 |
| 17 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1 |
0.0000 |
| 18 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1 |
0.0000 |
| 19 |
beta-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 20 |
Loop Diuretic [EPC] |
4 |
0.0000 |
| 21 |
Phosphodiesterase 5 Inhibitor [EPC] |
1 |
0.0000 |
| 22 |
Factor Xa Inhibitor [EPC] |
2 |
0.0000 |
| 23 |
Selective T Cell Costimulation Modulator [EPC] |
1 |
0.0000 |
| 24 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 25 |
Xanthine Oxidase Inhibitor [EPC] |
1 |
0.0000 |
| 26 |
Folate Analog Metabolic Inhibitor [EPC] |
2 |
0.0000 |
| 27 |
Opioid Agonist [EPC] |
1 |
0.0000 |
| 28 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 29 |
Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 30 |
Progestin [EPC] |
1 |
0.0000 |
| 31 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 32 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 33 |
Benzodiazepine [EPC] |
2 |
0.0000 |
| 34 |
Tumor Necrosis Factor Blocker [EPC] |
1 |
0.0000 |